摘要
背景:丝素蛋白(SF)是一种从家蚕(Bombyx mori)获得的天然原料,已被广泛用作具有优异机械性能的生物材料。据报道,SF是各种药物输送系统以及药物输送载体的有利生物聚合物之一。 目的:本综述总结了丝素蛋白在各种给药系统中的综合应用,并通过对丝素蛋白作为聚合物进行确定性评估,提出了目前的机会和要求。 结果:SF已被报道为用于各种给药系统以及给药载体的有益生物聚合物之一。 SF是无法估量的,因为它具有无毒和无抗原特性,除了在较低温度下储存时形成坚固性。与其他聚合物生物材料不同,SF在水性体系中以规定的温度,压力和pH值再生,这是其在配方中的主要优势之一。 SF纳米颗粒也用于递送蛋白质和肽。最近,SF已被用于递送抗癌剂如紫杉醇,多柔比星,氟尿苷和甲氨蝶呤,并且包括天然产物姜黄素,与其常规形式相比已显示出引起显着的生物活性。有趣的是,SF已被证明是一种用于植入物和注射药物递送应用的有前途的生物材料。 结论:在本综述中,我们总结了SF的物理和化学性质,生物相容性和非免疫原性特征及其在各种给药系统中的应用。
关键词: 生物材料,丝素蛋白,纳米粒,抗癌,药物传递,生物聚合物。
图形摘要
Current Drug Targets
Title:Silk Fibroin Based Drug Delivery Applications: Promises and Challenges
Volume: 19 Issue: 10
关键词: 生物材料,丝素蛋白,纳米粒,抗癌,药物传递,生物聚合物。
摘要: Background: Silk Fibroin (SF), a natural source material obtained from Bombyx mori, has been widely enlisted as biomaterial having outstanding mechanical properties. SF has been reported as one of the propitious bio-polymers for various drug delivery systems, as well as drug delivery vehicle.
Objective: This review is a summary of comprehensive applications of silk fibroin in various drug delivery systems, and also to present the current opportunities and requirements by furnishing a definitive assessment on silk fibroin as a polymer.
Results: SF has been reported as one of the propitious bio-polymers for various drug delivery systems, as well as drug delivery vehicle. SF is inestimable owing to its non-toxic and non-antigenic character, except for the firmness formation whilst being stored at lower temperature. Unlike other polymeric biomaterials, SF is regenerated in aqueous systems in defined temperature, pressure and pH, which is one of its major advantages in formulation. SF nanoparticles are also used to deliver proteins and peptides. Recently, SF has been used to deliver anti-cancer agents like paclitaxel, doxorubicin, floxuridine, and methotrexate, and including the natural product curcumin, has shown to elicit significant biological activity when compared to their conventional form. Interestingly, SF has shown to be a promising biomaterial for implantables and injectable drug delivery applications.
Conclusion: In the present review, we have summarized the physical and chemical properties, biocompatibility and non-immunogenic characters of SF and its applications in various drug delivery systems.
Export Options
About this article
Cite this article as:
Silk Fibroin Based Drug Delivery Applications: Promises and Challenges, Current Drug Targets 2018; 19 (10) . https://dx.doi.org/10.2174/1389450119666171227205525
DOI https://dx.doi.org/10.2174/1389450119666171227205525 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Probiotics: From Functional Foods to Pharmaceutical Products
Current Pharmaceutical Biotechnology Fibroblast Growth Factor 2: From Laboratory Evidence to Clinical Application
Current Vascular Pharmacology Cell Cycle Arrest and Apoptosis Induction of Phloroacetophenone Glycosides and Caffeoylquinic Acid Derivatives in Gastric Adenocarcinoma (AGS) Cells
Anti-Cancer Agents in Medicinal Chemistry Rationale and Design of the CAN Study: an RCT of Survival after Propofol- or Sevoflurane-based Anesthesia for Cancer Surgery
Current Pharmaceutical Design Ruthenium Complexes as Anticancer Agents
Current Medicinal Chemistry Hydrogen Sulphide: Biopharmacological Roles in the Cardiovascular System and Pharmaceutical Perspectives
Current Medicinal Chemistry Anti-cancer Therapies in High Grade Gliomas
Current Proteomics Investigating ABCB1-Mediated Drug-Drug Interactions: Considerations for In vitro and In vivo Assay Design
Current Drug Metabolism Hepatobiliary Diseases and Insulin Resistance
Current Medicinal Chemistry Porphyrins in Photodynamic Therapy - A Search for Ideal Photosensitizers
Current Medicinal Chemistry - Anti-Cancer Agents Self-immolative Linkers in Prodrugs and Antibody Drug Conjugates in Cancer Treatment
Recent Patents on Anti-Cancer Drug Discovery Trichinella spiralis and Tumors: Cause, Coincidence or Treatment?
Anti-Cancer Agents in Medicinal Chemistry Current Understanding of HSP90 as a Novel Therapeutic Target: An Emerging Approach for the Treatment of Cancer
Current Pharmaceutical Design The Targeted-liposome Delivery System of Antitumor Drugs
Current Drug Metabolism Erlotinib: A Targeted Anticancer Drug
Current Cancer Therapy Reviews Intraoperative Targeted Optical Imaging: A Guide towards Tumor-Free Margins in Cancer Surgery
Current Pharmaceutical Biotechnology Difluorinated Curcumin: A Promising Curcumin Analogue with Improved Anti-Tumor Activity and Pharmacokinetic Profile
Current Pharmaceutical Design Garlic and its Active Compounds: A Potential Candidate in The Prevention of Cancer by Modulating Various Cell Signalling Pathways
Anti-Cancer Agents in Medicinal Chemistry CpG Island Methylation in Precursors of Gastrointestinal Malignancies
Current Molecular Medicine Src Family Kinases in the Central Nervous System: Their Emerging Role in Pathophysiology of Migraine and Neuropathic Pain
Current Neuropharmacology